These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 681182)
41. Efficient production of large volumes of immune ascitic fluid from mice. Deig EF Arch Gesamte Virusforsch; 1974; 45(1-2):155-6. PubMed ID: 4413191 [No Abstract] [Full Text] [Related]
42. Demonstration of antifungal antibodies in hyperimmune mouse ascitic fluid by means of crossed immunoelectrophoresis. Hornok L; Szécsi A J Gen Microbiol; 1977 May; 100(1):213-6. PubMed ID: 874447 [No Abstract] [Full Text] [Related]
44. Production of large amounts of antibodies, nonspecific immunoglobulins, and other serum proteins in ascitic fluids of individual mice and guinea pigs. Tung AS Methods Enzymol; 1983; 93():12-23. PubMed ID: 6346008 [No Abstract] [Full Text] [Related]
45. [Device for fractionation of immune ascitic fluid during antibody concentration by the cryomethod]. Trofimov NM Vopr Virusol; 1976; (6):737-9. PubMed ID: 799872 [No Abstract] [Full Text] [Related]
46. Production of viral antibodies in ascitic fluid of mice. KASEL JA; LIEBERMAN R; SMITH HA Virology; 1959 Dec; 9():702-4. PubMed ID: 14404639 [No Abstract] [Full Text] [Related]
47. Purification process monitoring in monoclonal antibody preparation: contamination with viruses, DNA and peptide growth factors. ter Avest AR; van Zoelen EJ; Spijkers IE; Osterhaus AD; van Steenis G; van Kreyl CF Biologicals; 1992 Sep; 20(3):177-86. PubMed ID: 1457104 [TBL] [Abstract][Full Text] [Related]
48. Tumor cell-induced mouse ascites fluid as a source of viral antibodies. HERRMANN EC; ENGLE C Proc Soc Exp Biol Med; 1958 Jun; 98(2):257-9. PubMed ID: 13554611 [No Abstract] [Full Text] [Related]
49. Mouse antibody. I. Characterization and properties of antibody in mouse peritoneal fluid. ANACKER RL; MUNOZ J J Immunol; 1961 Oct; 87():426-32. PubMed ID: 13861073 [No Abstract] [Full Text] [Related]
51. Molecular cloning and characterization of the Ehrlichia chaffeensis variable-length PCR target: an antigen-expressing gene that exhibits interstrain variation. Sumner JW; Childs JE; Paddock CD J Clin Microbiol; 1999 May; 37(5):1447-53. PubMed ID: 10203503 [TBL] [Abstract][Full Text] [Related]
52. Production and characterization of monoclonal antibodies to Rickettsia rickettsii. Lange JV; Walker DH Infect Immun; 1984 Nov; 46(2):289-94. PubMed ID: 6209219 [TBL] [Abstract][Full Text] [Related]
53. [Preparation of hyperimmune mouse ascitic fluids for serodiagnostics and immunofluorescent evidence of Arboviri (author's transl)]. Hronovský V Cesk Epidemiol Mikrobiol Imunol; 1978 Jun; 27(3):129-36. PubMed ID: 151590 [No Abstract] [Full Text] [Related]
54. [Concentration of antibody to arboviruses in mouse immune ascitic fluid]. Gaidamovich SIa; Poliakova AN Vopr Virusol; 1975; (4):491-4. PubMed ID: 1240698 [TBL] [Abstract][Full Text] [Related]
55. Effect of adjuvant vaccines on dengue virus type 2 immune ascitic fluid production. Gamble WC; George EH; Fears MB; Sanderlin DW; Chappell WA J Clin Microbiol; 1985 Mar; 21(3):452-3. PubMed ID: 3980697 [TBL] [Abstract][Full Text] [Related]
56. The comparison of viral antibody titers of acid-precipitated and non-precipitated mouse ascitic fluids. Gamble WC; Chappell WA; George EH Health Lab Sci; 1978 Apr; 15(2):91-4. PubMed ID: 681182 [TBL] [Abstract][Full Text] [Related]
57. [Methods of obtaining polyvalent ascitic fluids immune to arboviruses in experiments on white mice]. Dumina AL Lab Delo; 1973; 6():329-32. PubMed ID: 4129383 [No Abstract] [Full Text] [Related]